✦ LIBER ✦

216 Preclinical evaluation of histone deacetylase inhibitors in malignant mesothelioma

✍ Scribed by Sharma, S.; Giraud, Y.; Dino, P.; Vogelzang, N.

Book ID: 118573899
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 69 KB
Volume: 54
Category: Article
ISSN: 0169-5002
DOI: 10.1016/s0169-5002(07)70292-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Preclinical studies of the proteasome in

Preclinical studies of the proteasome inhibitor bortezomib in malignant pleural mesothelioma

✍ Gavin J. Gordon; Madhubalan Mani; Gautam Maulik; Lipi Mukhopadhyay; Beow Y. Yeap 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 545 KB

312 POSTER Preclinical evaluation of a r

312 POSTER Preclinical evaluation of a rationally designed novel class of non-hydroxamate Histone Deacetylase inhibitors (HDACi)

✍ J.H. Gill; C.W.G. Fishwick; V. Androutsopoulos; A. Mohanarajah; T. Khamnaen; L.H 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 60 KB

Potential Role of Histone Deacetylase In

Potential Role of Histone Deacetylase Inhibitors in Mesothelioma: Clinical Experience with Suberoylanilide Hydroxamic Acid

✍ Lee M. Krug; Tracy Curley; Lawrence Schwartz; Stacie Richardson; Paul Marks; Jud 📂 Article 📅 2006 🏛 CIG Media Group, LP. 🌐 English ⚖ 564 KB

Activity of the histone deacetylase inhi

Activity of the histone deacetylase inhibitor belinostat (PXD101) in preclinical models of prostate cancer

✍ Xiaozhong Qian; Gulshan Ara; Evan Mills; William J. LaRochelle; Henri S. Lichens 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 751 KB

## Abstract Histone deacetylase inhibitors (HDACi) represent a promising new class of anticancer agents. In the current investigation, we examined the activity of the HDACi belinostat in preclinical models of prostate cancer. __In vitro__ proliferation assays demonstrated that belinostat potently i

135 Pediatric Preclinical Testing Progra

135 Pediatric Preclinical Testing Program (PPTP) stage 1 evaluation of JNJ-26481585, a second generation histone deacetylase inhibitor

✍ M.A. Smith; J.M. Maris; S.T. Keir; R.B. Lock; H. Carol; E.A. Kolb; M.H. Kang; C. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Preclinical data and early clinical expe

Preclinical data and early clinical experience supporting the use of histone deacetylase inhibitors in multiple myeloma

✍ Richardson, Paul G.; Mitsiades, Constantine S.; Laubach, Jacob P.; Hajek, Roman; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 616 KB